Company Overview and News

 
Aluminium price rallies

2018-04-18 thestar.com.my
SHANGHAI: Aluminium held near the highest in more than six years as the impact of US sanctions against Russia’s United Co Rusal dominated trading more than a week after they were announced, with buyers rushing to secure alternative supplies amid forecasts the price may hit US$3,000 a tonne.
Upvote Downvote

 
Aluminum Sanctions Convulse Market as Rally to $3,000 Forecast - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Australia, NZ shares fall following Wall Steet slump

2018-03-28 themalaymailonline
An investor reacts as he looks through a window at boards displaying stock prices at the Australian Securities Exchange (ASX) in Sydney, November 9, 2016. — Reuters picSYDNEY, March 28 — Australian shares slipped in thin trade this morning, as a sharp fall on Wall Street reduced risk appetite and pushed investors to the sidelines.
Upvote Downvote

 
38 Basic Materials 'Safer' Dividends For March

2018-03-28 seekingalpha
38 of 77 Basic Materials top yield stocks were tagged "safer" for dividends because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields 3/23/18.
Upvote Downvote

 
UPDATE 1-Japan Q2 aluminium premiums set at $129/T, highest in three years

2018-03-20 reuters
TOKYO, March 20 (Reuters) - Japanese aluminium buyers have agreed to pay producers premiums for supplies of the metal during the second quarter that are 25 percent higher than the first quarter, reflecting surging spot premiums in the United States, five sources directly involved in the quarterly pricing talks said.
Upvote Downvote

 
UPDATE 1-Aluminium producer offers Q2 shipments at 31 pct higher premium -sources

2018-02-23 reuters
TOKYO, Feb 23 (Reuters) - A global aluminium producer has offered Japanese buyers a premium of $135 per tonne for primary metal shipments during the April to June quarter, up 31 percent from the current quarter, three sources directly involved in the pricing talks said on Friday.
Upvote Downvote

 
Mercer, Schweitzer And Westlake Top 'Safer' Dividend Basic Materials February Gains

2018-02-21 seekingalpha
Top-gain ten "Safer" dividend Basic Materials stocks per analyst 1yr. targets, HUIHY; SHLTF; CELTF; LYB; AHGP; CPAC; ICL; WLKP, SWM, & MERC averaged 12.99% February net.
Upvote Downvote

 
BHP Rebuffs Elliott as First-Half Profit Hits Three-Year High - Bloomberg

2018-02-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
NCQ / NovaCopper Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-16 fintel.io
NovaCopper Inc. (AMEX:NCQ) has 42 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 42,442,992 shares. Largest shareholders include Paulson & Co. Inc., Baupost Group LLC/MA, South32 Ltd, Selz Capital LLC, Millennium Management Llc, Scoggin Llc, GMT Capital Corp, J. Goldman & Co LP, Renaissance Technologies LLC, and Manatuck Hill Partners, LLC.
Upvote Downvote

1
Resource Sector Digest: Pretium Coming Undone?

2018-02-01 seekingalpha
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
Upvote Downvote

 
SunCoke, Schweitzer And Westlake Pace 'Safer' Dividend Basic Materials Gains For January

2018-01-21 seekingalpha
Top-gain ten "Safer" dividend Basic Materials stocks per analyst 1yr. targets, SOUHY; RTNTF; ERELY; ICL; VEDL; HUIHY; AHGP; WLKP, SWM, & SXCP averaged 7.7% January gains.
Upvote Downvote

1
Top 5 Silver Stocks For 2018

2018-01-03 seekingalpha
2017 was a pretty tough year for silver stocks in general, and I admit that my top picks have not done very well.
Upvote Downvote

 
South32 Ltd - All Holdings - 13F 13D 13G Filings - Fintel.io

2017-12-29 fintel.io
South32 Ltd has disclosed 1 total holdings in their latest SEC filings. This investor has not filed a 13F, which indicates it has under $100M in Assets Under Management (AUM). South32 Ltd's top industries are "Metal Mining" (sic 10) .
Upvote Downvote

 
UPDATE 1-Japan aluminium premium raised to $103/T in Q1 -sources

2017-12-22 reuters
TOKYO, Dec 22 (Reuters) - Japanese aluminium buyers have agreed to pay producers a premium of $103 per tonne for metal shipped in the January-March quarter, reflecting higher spot premiums, five sources directly involved in the quarterly pricing talks said.
Upvote Downvote

 
Top Mining Stock Becomes 2017's Worst Loser on China Steel Shift - Bloomberg

2017-12-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 84473L105